Latest Atrion Corp (ATRI) Headlines Atrion Corp
Post# of 9
Posted On: 03/13/2014 5:35:51 AM
Latest Atrion Corp (ATRI) Headlines
Atrion Corporation Declares Quarterly Cash Dividend
Marketwire - Mon Mar 03, 4:47PM CST
The Board of Directors of Atrion Corporation (NASDAQ: ATRI) today announced its quarterly dividend of 64 cents per share on its outstanding shares of Common Stock. This dividend will be payable on March 31, 2014 to stockholders of record at the close of business on March 17, 2014.
Hyperion Therapeutics Announces the Publication of Phase 2 Results of Glycerol Phenylbutyrate (GPB) for the Treatment of Hepatic Encephalopathy in Hepatology
GlobeNewswire - Tue Feb 25, 9:25AM CST
Hyperion Therapeutics, Inc. (Nasdaq:HPTX) today announced that results of the Phase 2 trial of glycerol phenylbutyrate (GPB) for the treatment of hepatic encephalopathy (HE) were published in the March 2014 issue of Hepatology. The study met its primary endpoint with significantly fewer patients treated with GPB experiencing HE events as compared to patients receiving placebo.
Atrion Reports Fourth Quarter and Full Year 2013 Results
Marketwire - Mon Feb 24, 3:30PM CST
Atrion Corporation (NASDAQ: ATRI) announced today that for the fourth quarter of 2013 revenues were $31.9 million compared to $28.5 million in the same period of 2012, net income increased to $5.8 million from $4.9 million in last year's quarter, and diluted earnings per share were up to $2.87 from $2.42. For the full year 2013, Atrion's revenues increased to $132.0 million from $119.1 million in 2012, net income was up to $26.6 million from $23.6 million, while diluted earnings per share increased to $13.18 from $11.66 in 2012.
KMM Expands National Distribution Network with New Texas Facility
PR Newswire - Thu Jan 23, 9:00AM CST
KMM, a leader in supply chain and logistics services to the U.S. communications industry, has expanded its national distribution network with a 200,000 sq. ft. facility in Grapevine, Texas.
Atrion Shares Up 18.4% Since SmarTrend's Buy Recommendation (ATRI)
Comtex SmarTrend(R) - Wed Jan 15, 11:19AM CST
SmarTrend identified an Uptrend for Atrion (NASDAQ:ATRI) on September 16th, 2013 at $244.73. In approximately 4 months, Atrion has returned 18.36% as of today's recent price of $289.65.
Atrion Shares Up 21.1% Since SmarTrend's Buy Recommendation (ATRI)
Comtex SmarTrend(R) - Wed Jan 08, 10:03AM CST
SmarTrend identified an Uptrend for Atrion (NASDAQ:ATRI) on September 16th, 2013 at $244.73. In approximately 4 months, Atrion has returned 21.10% as of today's recent price of $296.35.
The Small-Cap Screen That Beats the Market
at The Street - Tue Jan 07, 7:49AM CST
Can small-cap dividend growers outperform again in 2014?
Atrion Up 21.6% Since SmarTrend Uptrend Call (ATRI)
Comtex SmarTrend(R) - Tue Dec 31, 11:17AM CST
SmarTrend identified an Uptrend for Atrion (NASDAQ:ATRI) on September 16th, 2013 at $244.73. In approximately 4 months, Atrion has returned 21.60% as of today's recent price of $297.59.
Atrion Reports Third Quarter Results
Marketwire - Tue Oct 29, 3:30PM CDT
Atrion Corporation (NASDAQ: ATRI) today announced that for the third quarter of 2013 revenues and operating income were up 11% and diluted earnings per share were up 6% compared to the results for the third quarter of 2012.
26.2% Return Seen to Date on SmarTrend Atrion Call (ATRI)
Comtex SmarTrend(R) - Mon Aug 26, 11:03AM CDT
SmarTrend identified an Uptrend for Atrion (NASDAQ:ATRI) on April 18th, 2013 at $198.72. In approximately 4 months, Atrion has returned 26.19% as of today's recent price of $250.76.
Atrion Corporation reports 14% rise in dividend
M2 - Thu Aug 15, 7:56AM CDT
The board of directors of Atrion Corporation (NASDAQ:ATRI), a provider of products primarily for medical applications, on Wednesday declared a quarterly dividend of USD0.64 per share on the company's outstanding shares of common stock.
Atrion Corporation Increases Quarterly Cash Dividend by 14%
Marketwire - Wed Aug 14, 3:30PM CDT
Atrion Corporation (NASDAQ: ATRI) today announced an increase in its quarterly cash dividend from 56 cents per share to 64 cents per share. Specifically, the Board of Directors declared a quarterly dividend of 64 cents per share on its outstanding shares of Common Stock. This dividend will be payable on September 30, 2013 to stockholders of record at the close of business on September 13, 2012.
ATRION Increases Sales but Misses Estimates on Earnings
Seth Jayson, The Motley Fool - Motley Fool - Thu Aug 01, 11:47AM CDT
ATRION ( NASDAQ: ATRI ) reported earnings on July 31. Here are the numbers you need to know. The 10-second takeaway For the quarter ended June 30 (Q2), ATRION missed estimates on revenues and missed estimates on earnings per share. ...
Atrion Reports Second Quarter Results
Marketwire - Wed Jul 31, 3:30PM CDT
Atrion Corporation (NASDAQ: ATRI) today announced that for the second quarter of 2013 diluted earnings per share were up 7% and revenues were up 6% compared to the results for the second quarter of 2012.
Uptrend Call Working As Atrion Stock Rises 22.3% (ATRI)
Comtex SmarTrend(R) - Fri Jul 26, 11:08AM CDT
SmarTrend identified an Uptrend for Atrion (NASDAQ:ATRI) on April 18th, 2013 at $198.72. In approximately 3 months, Atrion has returned 22.26% as of today's recent price of $242.95.
Atrion Corporation Declares Quarterly Cash Dividend
Marketwire - Mon Mar 03, 4:47PM CST
The Board of Directors of Atrion Corporation (NASDAQ: ATRI) today announced its quarterly dividend of 64 cents per share on its outstanding shares of Common Stock. This dividend will be payable on March 31, 2014 to stockholders of record at the close of business on March 17, 2014.
Hyperion Therapeutics Announces the Publication of Phase 2 Results of Glycerol Phenylbutyrate (GPB) for the Treatment of Hepatic Encephalopathy in Hepatology
GlobeNewswire - Tue Feb 25, 9:25AM CST
Hyperion Therapeutics, Inc. (Nasdaq:HPTX) today announced that results of the Phase 2 trial of glycerol phenylbutyrate (GPB) for the treatment of hepatic encephalopathy (HE) were published in the March 2014 issue of Hepatology. The study met its primary endpoint with significantly fewer patients treated with GPB experiencing HE events as compared to patients receiving placebo.
Atrion Reports Fourth Quarter and Full Year 2013 Results
Marketwire - Mon Feb 24, 3:30PM CST
Atrion Corporation (NASDAQ: ATRI) announced today that for the fourth quarter of 2013 revenues were $31.9 million compared to $28.5 million in the same period of 2012, net income increased to $5.8 million from $4.9 million in last year's quarter, and diluted earnings per share were up to $2.87 from $2.42. For the full year 2013, Atrion's revenues increased to $132.0 million from $119.1 million in 2012, net income was up to $26.6 million from $23.6 million, while diluted earnings per share increased to $13.18 from $11.66 in 2012.
KMM Expands National Distribution Network with New Texas Facility
PR Newswire - Thu Jan 23, 9:00AM CST
KMM, a leader in supply chain and logistics services to the U.S. communications industry, has expanded its national distribution network with a 200,000 sq. ft. facility in Grapevine, Texas.
Atrion Shares Up 18.4% Since SmarTrend's Buy Recommendation (ATRI)
Comtex SmarTrend(R) - Wed Jan 15, 11:19AM CST
SmarTrend identified an Uptrend for Atrion (NASDAQ:ATRI) on September 16th, 2013 at $244.73. In approximately 4 months, Atrion has returned 18.36% as of today's recent price of $289.65.
Atrion Shares Up 21.1% Since SmarTrend's Buy Recommendation (ATRI)
Comtex SmarTrend(R) - Wed Jan 08, 10:03AM CST
SmarTrend identified an Uptrend for Atrion (NASDAQ:ATRI) on September 16th, 2013 at $244.73. In approximately 4 months, Atrion has returned 21.10% as of today's recent price of $296.35.
The Small-Cap Screen That Beats the Market
at The Street - Tue Jan 07, 7:49AM CST
Can small-cap dividend growers outperform again in 2014?
Atrion Up 21.6% Since SmarTrend Uptrend Call (ATRI)
Comtex SmarTrend(R) - Tue Dec 31, 11:17AM CST
SmarTrend identified an Uptrend for Atrion (NASDAQ:ATRI) on September 16th, 2013 at $244.73. In approximately 4 months, Atrion has returned 21.60% as of today's recent price of $297.59.
Atrion Reports Third Quarter Results
Marketwire - Tue Oct 29, 3:30PM CDT
Atrion Corporation (NASDAQ: ATRI) today announced that for the third quarter of 2013 revenues and operating income were up 11% and diluted earnings per share were up 6% compared to the results for the third quarter of 2012.
26.2% Return Seen to Date on SmarTrend Atrion Call (ATRI)
Comtex SmarTrend(R) - Mon Aug 26, 11:03AM CDT
SmarTrend identified an Uptrend for Atrion (NASDAQ:ATRI) on April 18th, 2013 at $198.72. In approximately 4 months, Atrion has returned 26.19% as of today's recent price of $250.76.
Atrion Corporation reports 14% rise in dividend
M2 - Thu Aug 15, 7:56AM CDT
The board of directors of Atrion Corporation (NASDAQ:ATRI), a provider of products primarily for medical applications, on Wednesday declared a quarterly dividend of USD0.64 per share on the company's outstanding shares of common stock.
Atrion Corporation Increases Quarterly Cash Dividend by 14%
Marketwire - Wed Aug 14, 3:30PM CDT
Atrion Corporation (NASDAQ: ATRI) today announced an increase in its quarterly cash dividend from 56 cents per share to 64 cents per share. Specifically, the Board of Directors declared a quarterly dividend of 64 cents per share on its outstanding shares of Common Stock. This dividend will be payable on September 30, 2013 to stockholders of record at the close of business on September 13, 2012.
ATRION Increases Sales but Misses Estimates on Earnings
Seth Jayson, The Motley Fool - Motley Fool - Thu Aug 01, 11:47AM CDT
ATRION ( NASDAQ: ATRI ) reported earnings on July 31. Here are the numbers you need to know. The 10-second takeaway For the quarter ended June 30 (Q2), ATRION missed estimates on revenues and missed estimates on earnings per share. ...
Atrion Reports Second Quarter Results
Marketwire - Wed Jul 31, 3:30PM CDT
Atrion Corporation (NASDAQ: ATRI) today announced that for the second quarter of 2013 diluted earnings per share were up 7% and revenues were up 6% compared to the results for the second quarter of 2012.
Uptrend Call Working As Atrion Stock Rises 22.3% (ATRI)
Comtex SmarTrend(R) - Fri Jul 26, 11:08AM CDT
SmarTrend identified an Uptrend for Atrion (NASDAQ:ATRI) on April 18th, 2013 at $198.72. In approximately 3 months, Atrion has returned 22.26% as of today's recent price of $242.95.
(0)
(0)Atrion Corp. (ATRI) Stock Research Links
Scroll down for more posts ▼